Pfizer's bipolar disorder drug Geodon receives expanded FDA approval Pfizer Inc. said Friday the Food and Drug Administration approved Geodon as a part ...
FDA panel backs stronger benefit claims for inhaler drug Spiriva marketed by Pfizer Federal health experts say an inhaler drug from a German ...
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said on Wednesday it would conduct a new late-stage trial to evaluate the effect of one of its drug candidates in combating a thickening of the arteries in patients. The Phase III trial is ...
ORLANDO, Florida (Reuters) - High doses of an experimental heart medicine being developed by Merck & Co MRK.N continued to show beneficial effects on both good HDL and bad LDL cholesterol levels eight weeks after patients stopped taking the drug, in a ...
With Pfizer leaving, residents of Conn. city say fight over waterfront land was unnecessary After drug giant Pfizer Inc. announced that it was opening a new research center here, city officials aggressively moved to acquire surrounding land for an economic development project ...
Analysis of a dozen published studies testing possible new uses for a Pfizer Inc. epilepsy drug found that reporting of the results was often misleading, indicating the medicine worked better than internal company documents showed. According to the report, when a company-funded ...
Pfizer pullout from Connecticut city puzzles those who lost key eminent domain case Now that drug giant Pfizer Inc. has announced plans to pull out of a Connecticut city that was embroiled in an epic eminent domain fight, residents are questioning why ...
FILE - In this April 12, 2005 file photo, the world headquarters of Pfizer Inc. is shown in New York. In April, 2009, the FDA fired off warning letters to Pfizer Inc., GlaxoSmithKline and a dozen other drugmakers for search engine ads ...
FILE - In this Jan. 25, 2009 file photo, a sign at Pfizer world headquarters in New York is shown. Analysis of a dozen published studies testing possible new uses for a Pfizer Inc. epilepsy drug found that reporting of the results ...
CHICAGO (Reuters) - A study of internal company documents suggests Pfizer Inc altered or omitted unfavorable study findings to expand its epilepsy drug Neurontin's market, U.S. researchers said on Wednesday, offering a look at how drugmakers influence scientific research. Clinical trials are ...
Pfizer Inc., which just acquired fellow drugmaker Wyeth, is closing six of the two companies' research sites and keeping open 14 others. Two Cambridge, Mass., sites will operate as one. Following is a list of the sites: Former Wyeth sites staying open/Types ...
Pfizer closing some research plants, consolidating others and cutting staff after buying Wyeth Less than a month after buying Wyeth, drug giant Pfizer Inc. has mapped out a new structure for its research and development operations. The plan, announced Monday, will bring ...
